• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-92a-3p和miR-320a在额颞叶痴呆患者血浆神经元来源的细胞外囊泡中上调。

miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia.

作者信息

Manzini Valeria, Cappelletti Pamela, Orefice Nicola S, Brentari Ilaria, Rigby Michael J, Lo Giudice Maria, Feligioni Marco, Rivabene Roberto, Crestini Alessio, Manfredi Francesco, Talarico Giuseppina, Bruno Giuseppe, Corbo Massimo, Puglielli Luigi, Denti Michela A, Piscopo Paola

机构信息

Department of Neuroscience, Istituto Superiore Di Sanità, Viale Regina Elena, 299, 00161, Rome, Italy.

Department of Biology and Biotechnology Charles Darwin, University of Rome "Sapienza", Rome, Italy.

出版信息

Mol Neurobiol. 2025 Feb;62(2):2573-2586. doi: 10.1007/s12035-024-04386-z. Epub 2024 Aug 14.

DOI:10.1007/s12035-024-04386-z
PMID:39138758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11772464/
Abstract

Despite the efforts to identify fluid biomarkers to improve diagnosis of Frontotemporal dementia (FTD), only a few candidates have been described in recent years. In a previous study, we identified three circulating miRNAs (miR-92a-3p, miR-320a and miR-320b) differentially expressed in FTD patients with respect to healthy controls and/or Alzheimer's disease (AD) patients. Now, we investigated whether those changes could be due to miRNAs contained in neuron-derived extracellular vesicles (NDEVs). We also evaluated miRNAs content in total plasma EVs and in CSF samples. The analysis of plasma NDEVs carried out on 40 subjects including controls (n = 13), FTD (n = 13) and AD (n = 14) patients, showed that both miR-92a-3p and miR-320a levels were triplicated in the FTD group if compared with CT and AD patients. Increased levels of the same miRNAs were found also in CSF derived from FTD group compared to CTs. No differences were observed in expression levels of miR-320b among the three groups. Worthy of note, all miRNAs analysed were increased in an FTD cell model, MAPT IVS10 + 16 neurons. Our results suggest that miR-92a and miR-320a in NDEVs could be proposed as FTD biomarkers.

摘要

尽管人们努力寻找可改善额颞叶痴呆(FTD)诊断的体液生物标志物,但近年来仅有少数几种候选物被报道。在之前的一项研究中,我们鉴定出三种循环miRNA(miR-92a-3p、miR-320a和miR-320b)在FTD患者中相对于健康对照和/或阿尔茨海默病(AD)患者存在差异表达。现在,我们研究了这些变化是否可能归因于神经元衍生的细胞外囊泡(NDEVs)中所含的miRNA。我们还评估了总血浆细胞外囊泡(EVs)和脑脊液样本中的miRNA含量。对包括对照组(n = 13)、FTD患者(n = 13)和AD患者(n = 14)在内的40名受试者进行的血浆NDEVs分析表明,与对照组和AD患者相比,FTD组中miR-92a-3p和miR-320a的水平均增加了两倍。与对照组相比,FTD组脑脊液中相同miRNA的水平也有所升高。三组间miR-320b的表达水平未观察到差异。值得注意的是,在FTD细胞模型MAPT IVS10 + 16神经元中,所有分析的miRNA水平均升高。我们的结果表明,NDEVs中的miR-92a和miR-320a可被提议作为FTD的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/00626a89a8ba/12035_2024_4386_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/04ac0d9d39aa/12035_2024_4386_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/f123667968f1/12035_2024_4386_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/2358401436df/12035_2024_4386_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/9f139492f2f0/12035_2024_4386_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/8a214502986c/12035_2024_4386_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/00626a89a8ba/12035_2024_4386_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/04ac0d9d39aa/12035_2024_4386_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/f123667968f1/12035_2024_4386_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/2358401436df/12035_2024_4386_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/9f139492f2f0/12035_2024_4386_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/8a214502986c/12035_2024_4386_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bc/11772464/00626a89a8ba/12035_2024_4386_Fig6_HTML.jpg

相似文献

1
miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia.miR-92a-3p和miR-320a在额颞叶痴呆患者血浆神经元来源的细胞外囊泡中上调。
Mol Neurobiol. 2025 Feb;62(2):2573-2586. doi: 10.1007/s12035-024-04386-z. Epub 2024 Aug 14.
2
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia.调控微管相关蛋白tau(MAPT)表达的微小RNA(miRNA)的鉴定及其在痴呆患者血浆中的分析
Front Mol Neurosci. 2023 May 31;16:1127163. doi: 10.3389/fnmol.2023.1127163. eCollection 2023.
3
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.与突触功能相关的改变的 microRNAs 作为阿尔茨海默病的潜在血浆生物标志物。
Alzheimers Res Ther. 2019 May 15;11(1):46. doi: 10.1186/s13195-019-0501-4.
4
Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.循环 miR-127-3p 作为额颞叶痴呆鉴别诊断的潜在生物标志物。
J Alzheimers Dis. 2018;65(2):455-464. doi: 10.3233/JAD-180364.
5
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease.阿尔茨海默病患者血浆神经来源的小细胞外囊泡中的 miRNA 谱分析。
Cells. 2020 Jun 10;9(6):1443. doi: 10.3390/cells9061443.
6
Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal Dementia.早发型阿尔茨海默病和额颞叶痴呆患者脑脊液外泌体微小RNA水平的改变
J Alzheimers Dis Rep. 2021 Oct 28;5(1):805-813. doi: 10.3233/ADR-210311. eCollection 2021.
7
Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls.特定的血清和脑脊液 microRNA 谱可区分散发性行为变异型额颞叶痴呆与阿尔茨海默病患者和认知健康对照者。
PLoS One. 2018 May 10;13(5):e0197329. doi: 10.1371/journal.pone.0197329. eCollection 2018.
8
Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer's Disease and Frontotemporal Dementia.探索微小RNA作为阿尔茨海默病和额颞叶痴呆血液生物标志物的作用。
Int J Mol Sci. 2025 Apr 5;26(7):3399. doi: 10.3390/ijms26073399.
9
MicroRNA expression within neuronal-derived small extracellular vesicles in frontotemporal degeneration.神经元来源的小细胞外囊泡中的 microRNA 表达在额颞叶变性中的作用。
Medicine (Baltimore). 2022 Oct 7;101(40):e30854. doi: 10.1097/MD.0000000000030854.
10
Preclinical Alzheimer's disease shows alterations in circulating neuronal-derived extracellular vesicle microRNAs in a multiethnic cohort.临床前阿尔茨海默病在一个多民族队列中显示出循环神经元衍生细胞外囊泡微小RNA的改变。
Alzheimers Dement. 2025 Mar;21(3):e70050. doi: 10.1002/alz.70050.

引用本文的文献

1
Role of CPEBs in Learning and Memory.CPEB 在学习与记忆中的作用。
J Neurochem. 2025 Sep;169(9):e70226. doi: 10.1111/jnc.70226.
2
Clinical value of high-frequency ultrasound and serum miR-92a-3p in diabetic peripheral neuropathy.高频超声与血清miR-92a-3p在糖尿病周围神经病变中的临床价值
J Diabetes Investig. 2025 Sep;16(9):1692-1703. doi: 10.1111/jdi.70110. Epub 2025 Jul 4.
3
Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer's Disease and Frontotemporal Dementia.探索微小RNA作为阿尔茨海默病和额颞叶痴呆血液生物标志物的作用。

本文引用的文献

1
Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease.前驱期阿尔茨海默病中外泌体 miRNA 谱的改变。
Int J Mol Sci. 2023 Sep 29;24(19):14749. doi: 10.3390/ijms241914749.
2
The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer's disease.唾液外泌体富集细胞外囊泡中的 microRNA-485-3p 浓度与阿尔茨海默病患者大脑中的淀粉样 β 沉积有关。
Clin Biochem. 2023 Aug;118:110603. doi: 10.1016/j.clinbiochem.2023.110603. Epub 2023 Jun 22.
3
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia.
Int J Mol Sci. 2025 Apr 5;26(7):3399. doi: 10.3390/ijms26073399.
调控微管相关蛋白tau(MAPT)表达的微小RNA(miRNA)的鉴定及其在痴呆患者血浆中的分析
Front Mol Neurosci. 2023 May 31;16:1127163. doi: 10.3389/fnmol.2023.1127163. eCollection 2023.
4
Small Extracellular Vesicles' miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases.小细胞外囊泡中的微小RNA:神经退行性疾病的生物标志物与治疗手段
Pharmaceutics. 2023 Apr 11;15(4):1216. doi: 10.3390/pharmaceutics15041216.
5
Precise profiling of exosomal biomarkers via programmable curved plasmonic nanoarchitecture-based biosensor for clinical diagnosis of Alzheimer's disease.通过基于可编程弯曲等离子体纳米结构的生物传感器对阿尔茨海默病进行临床诊断时对外泌体生物标志物的精确分析。
Biosens Bioelectron. 2023 Jun 15;230:115269. doi: 10.1016/j.bios.2023.115269. Epub 2023 Mar 28.
6
Recent advances in isolation and detection of exosomal microRNAs related to Alzheimer's disease.近年来阿尔茨海默病相关外泌体 microRNAs 的分离与检测技术的进展。
Environ Res. 2023 Jun 15;227:115705. doi: 10.1016/j.envres.2023.115705. Epub 2023 Mar 21.
7
A Plasma Circular RNA Profile Differentiates Subjects with Alzheimer's Disease and Mild Cognitive Impairment from Healthy Controls.血浆环状 RNA 谱可区分阿尔茨海默病和轻度认知障碍患者与健康对照者。
Int J Mol Sci. 2022 Oct 31;23(21):13232. doi: 10.3390/ijms232113232.
8
MicroRNA expression within neuronal-derived small extracellular vesicles in frontotemporal degeneration.神经元来源的小细胞外囊泡中的 microRNA 表达在额颞叶变性中的作用。
Medicine (Baltimore). 2022 Oct 7;101(40):e30854. doi: 10.1097/MD.0000000000030854.
9
Syntaxin-1a and SNAP-25 expression level is increased in the blood samples of ischemic stroke patients.缺血性脑卒中患者血液样本中突触融合蛋白 1a 和突触融合蛋白 25 的表达水平升高。
Sci Rep. 2022 Aug 25;12(1):14483. doi: 10.1038/s41598-022-18719-2.
10
Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer's Disease.失调的 microRNAs 在阿尔茨海默病的进展和发病机制中的作用。
Mol Neurobiol. 2022 Oct;59(10):6107-6124. doi: 10.1007/s12035-022-02950-z. Epub 2022 Jul 22.